JP2024541481A5 - - Google Patents
Info
- Publication number
- JP2024541481A5 JP2024541481A5 JP2024531070A JP2024531070A JP2024541481A5 JP 2024541481 A5 JP2024541481 A5 JP 2024541481A5 JP 2024531070 A JP2024531070 A JP 2024531070A JP 2024531070 A JP2024531070 A JP 2024531070A JP 2024541481 A5 JP2024541481 A5 JP 2024541481A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- independently
- heteroaryl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163283127P | 2021-11-24 | 2021-11-24 | |
| US63/283,127 | 2021-11-24 | ||
| PCT/US2022/050914 WO2023097007A1 (en) | 2021-11-24 | 2022-11-23 | Compounds and methods for modulating splicing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541481A JP2024541481A (ja) | 2024-11-08 |
| JP2024541481A5 true JP2024541481A5 (https=) | 2026-01-08 |
Family
ID=84602127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531070A Pending JP2024541481A (ja) | 2021-11-24 | 2022-11-23 | スプライシングを調整するための化合物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250082633A1 (https=) |
| EP (1) | EP4436961A1 (https=) |
| JP (1) | JP2024541481A (https=) |
| KR (1) | KR20240149387A (https=) |
| CN (1) | CN118804912A (https=) |
| AU (1) | AU2022398247A1 (https=) |
| CA (1) | CA3239110A1 (https=) |
| WO (1) | WO2023097007A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250353841A1 (en) * | 2022-05-20 | 2025-11-20 | Sarah Elizabeth Huff | Heterocyclic compounds for treating huntington's disease |
| WO2025111409A1 (en) * | 2023-11-21 | 2025-05-30 | Biogen Ma Inc. | Heterocyclic compounds of formula (i) for use in the treatment of spinal muscular atrophy via modulation of smn2 splicing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY34750A (es) * | 2012-04-20 | 2013-11-29 | Gilead Sciences Inc | ?compuestos para el tratamiento del hiv, composiciones,métodos de preparación, intermediarios y métodos terapéuticos?. |
| EP3119763A1 (en) * | 2014-03-18 | 2017-01-25 | Iteos Therapeutics | Novel 3-indol substituted derivatives, pharmaceutical compositions and methods for use |
| EP3523289A1 (en) * | 2016-10-07 | 2019-08-14 | Araxes Pharma LLC | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
| JP2023520916A (ja) * | 2020-04-08 | 2023-05-22 | リミックス セラピューティクス インコーポレイテッド | スプライシングを調整するための化合物及び方法 |
| KR20230005210A (ko) * | 2020-04-08 | 2023-01-09 | 레믹스 테라퓨틱스 인크. | 스플라이싱을 조절하기 위한 화합물 및 방법 |
-
2022
- 2022-11-23 AU AU2022398247A patent/AU2022398247A1/en active Pending
- 2022-11-23 CA CA3239110A patent/CA3239110A1/en active Pending
- 2022-11-23 KR KR1020247020813A patent/KR20240149387A/ko active Pending
- 2022-11-23 JP JP2024531070A patent/JP2024541481A/ja active Pending
- 2022-11-23 US US18/713,561 patent/US20250082633A1/en active Pending
- 2022-11-23 WO PCT/US2022/050914 patent/WO2023097007A1/en not_active Ceased
- 2022-11-23 EP EP22830059.6A patent/EP4436961A1/en active Pending
- 2022-11-23 CN CN202280085944.6A patent/CN118804912A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515617A5 (https=) | ||
| JP2023520924A5 (https=) | ||
| JP2023515618A5 (https=) | ||
| JP2024541481A5 (https=) | ||
| JP2023520925A5 (https=) | ||
| JP6704421B2 (ja) | Ｄｎａアルキル化剤 | |
| IL295957A (en) | Compounds and methods for modulating splicing | |
| JP6466348B2 (ja) | スルファモイル−アリールアミドおよびｂ型肝炎を処置するための医薬品としてのその使用 | |
| IL295955A (en) | Compounds and methods for modulating splicing | |
| JP2018530587A5 (https=) | ||
| JP2007507542A5 (https=) | ||
| RU2020123151A (ru) | Антагонисты tlr7/8 и их применение | |
| JP6427096B2 (ja) | 新規なアルファ２アドレナリン受容体アゴニスト | |
| JP2011510068A5 (https=) | ||
| JP2018517731A5 (https=) | ||
| RU2017120970A (ru) | Производные желчной кислоты в качестве агонистов fxr/tgr5 и способы их применения | |
| RU2020112502A (ru) | Циклические динуклеотиды в качестве стимулятора модуляторов генов интерферона | |
| JP7181938B2 (ja) | ホスホロ（ン）アミダートアセタールおよびホスファ（ホナ）ートアルセタール化合物 | |
| JP2017526614A5 (https=) | ||
| IL287159B2 (en) | Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use | |
| JP2021533206A5 (https=) | ||
| KR20190129034A (ko) | 금속효소 억제제 화합물 | |
| EP2462139B1 (en) | Sphingosine-1-phosphate receptor agonists | |
| JP2004525183A5 (https=) | ||
| JP7422741B2 (ja) | ２－［（３ｒ）－３－メチルモルホリン－４－イル］－４－（１－メチル－１ｈ－ピラゾール－５－イル）－８－（１ｈ－ピラゾール－５－イル）－１，７－ナフチリジンを調製する方法 |